Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease‐modifying anti‐rheumatic drugs for at least 6 months

Abstract

In this study, higher DAS was one of the most influential factors for poor PROs among all other factors. Therefore, we could suggest appropriate treatment approaches according to DAS along with other significantly associated factors with PROs in the early stage of RA.